PL1753725T3 - Pochodne tetrahydroizochinolino sulfonamidowe, ich wytwarzanie oraz ich zastosowanie w leczeniu - Google Patents

Pochodne tetrahydroizochinolino sulfonamidowe, ich wytwarzanie oraz ich zastosowanie w leczeniu

Info

Publication number: PL1753725T3
Authority: PL; Poland
Prior art keywords: therapeutics; preparation; same; sulfonamide derivatives; tetrahydroisoquinoline
Prior art date: 2004-05-25

Application number

PL05772938T

Other languages

English (en)

Inventor

Martin Juan Antonio Diaz

Bargueno Maria Dolores Jimenez

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-25

Filing date

2005-05-24

Publication date

2013-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34944870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1753725(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-05-24 Application filed by Sanofi Sa filed Critical Sanofi Sa

2013-07-31 Publication of PL1753725T3 publication Critical patent/PL1753725T3/pl

Links

XQIXMQKCQHXOLH-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline-1-sulfonamide Chemical class C1=CC=C2C(S(=O)(=O)N)NCCC2=C1 XQIXMQKCQHXOLH-UHFFFAOYSA-N 0.000 title 1
239000003814 drug Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)
Gynecology & Obstetrics (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL05772938T 2004-05-25 2005-05-24 Pochodne tetrahydroizochinolino sulfonamidowe, ich wytwarzanie oraz ich zastosowanie w leczeniu PL1753725T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0405607A FR2870846B1 (fr)	2004-05-25	2004-05-25	Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
EP05772938A EP1753725B1 (fr)	2004-05-25	2005-05-24	Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique
PCT/FR2005/001279 WO2005118547A1 (fr)	2004-05-25	2005-05-24	Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique

Publications (1)

Publication Number	Publication Date
PL1753725T3 true PL1753725T3 (pl)	2013-07-31

Family

ID=34944870

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05772938T PL1753725T3 (pl)	2004-05-25	2005-05-24	Pochodne tetrahydroizochinolino sulfonamidowe, ich wytwarzanie oraz ich zastosowanie w leczeniu

Country Status (40)

Country	Link
US (3)	US7833999B2 (pl)
EP (1)	EP1753725B1 (pl)
JP (1)	JP4861979B2 (pl)
KR (1)	KR101176675B1 (pl)
CN (1)	CN1956962B (pl)
AR (1)	AR050250A1 (pl)
AU (1)	AU2005250197B2 (pl)
BR (1)	BRPI0511581A (pl)
CA (1)	CA2565293C (pl)
CR (1)	CR8735A (pl)
CY (1)	CY1114240T1 (pl)
DK (1)	DK1753725T3 (pl)
DO (1)	DOP2005000103A (pl)
EA (1)	EA010234B1 (pl)
EC (1)	ECSP067020A (pl)
ES (1)	ES2407140T3 (pl)
FR (1)	FR2870846B1 (pl)
GT (1)	GT200500126A (pl)
HN (1)	HN2005000239A (pl)
HR (1)	HRP20130431T1 (pl)
IL (1)	IL179021A (pl)
JO (1)	JO2877B1 (pl)
MA (1)	MA28720B1 (pl)
MX (1)	MXPA06013629A (pl)
MY (1)	MY148980A (pl)
NI (1)	NI200600279A (pl)
NO (1)	NO338104B1 (pl)
NZ (1)	NZ551509A (pl)
PA (1)	PA8634501A1 (pl)
PE (1)	PE20060273A1 (pl)
PL (1)	PL1753725T3 (pl)
PT (1)	PT1753725E (pl)
SI (1)	SI1753725T1 (pl)
SV (1)	SV2006002126A (pl)
TN (1)	TNSN06356A1 (pl)
TW (1)	TWI360540B (pl)
UA (1)	UA84771C2 (pl)
UY (1)	UY28917A1 (pl)
WO (1)	WO2005118547A1 (pl)
ZA (1)	ZA200609820B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2870846B1 (fr) *	2004-05-25	2006-08-04	Sanofi Synthelabo	Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
EP1790646A1 (fr) *	2005-11-24	2007-05-30	Sanofi-Aventis	Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3.
CN101855211B (zh)	2007-11-13	2013-06-12	大正制药株式会社	苯基吡唑衍生物
TW201039822A (en)	2009-02-06	2010-11-16	Taisho Pharmaceutical Co Ltd	Dihydroquinolinone derivatives
NZ597219A (en) *	2009-06-26	2013-05-31	Sanofi Sa	Novel fumarate salts of a histamine h3 receptor antagonist
AR080375A1 (es) *	2010-03-05	2012-04-04	Sanofi Aventis	Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida
BR112014013461A2 (pt)	2011-12-08	2017-06-13	Taisho Pharmaceutical Co Ltd	derivado de fenilpirrol
WO2013100054A1 (ja)	2011-12-27	2013-07-04	大正製薬株式会社	フェニルトリアゾール誘導体
EP2647377A1 (en) *	2012-04-06	2013-10-09	Sanofi	Use of an h3 receptor antagonist for the treatment of alzheimer's disease
EP3043799A1 (en) *	2013-09-09	2016-07-20	Sanofi	An h3 receptor antagonist combined with a cholinesterase inhibitor for use in the treatment of alzheimer's disease
CN110642854A (zh) *	2019-11-20	2020-01-03	成都克莱蒙医药科技有限公司	一种稠环化合物的多晶型、其组合物、制备方法及其应用
EP4251148A1 (en)	2020-11-27	2023-10-04	Richter Gedeon Nyrt.	Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH08511538A (ja)	1993-06-09	1996-12-03	スミスクライン・ビーチャム・コーポレイション	二環式フィブリノゲン拮抗物質
GB9508622D0 (en)	1995-04-28	1995-06-14	Pfizer Ltd	Therapeutic agants
EP0882023B1 (en) *	1996-02-09	2003-06-04	James Black Foundation Limited	Histamine h 3 receptor ligands
SK15072000A3 (sk)	1998-04-10	2001-08-06	Japan Tobacco Inc.	Amidové zlúčeniny
US6545055B1 (en)	1999-05-24	2003-04-08	Millennium Pharmaceuticals, Inc.	Inhibitors of factor Xa
CA2432578C (en)	2001-01-02	2008-04-01	F. Hoffmann-La Roche Ag	Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
JP2004532834A (ja) *	2001-03-23	2004-10-28	イーライ・リリー・アンド・カンパニー	ヒスタミンｈ３受容体アンタゴニストである非イミダゾール系アリールアルキルアミン化合物、その製造および治療的使用
JP2003192660A (ja) *	2001-12-26	2003-07-09	Bayer Ag	尿素誘導体
WO2003055848A2 (en) *	2001-12-26	2003-07-10	Bayer Healthcare Ag	Urea derivatives as vr1- antagonists
KR100984655B1 (ko)	2002-03-08	2010-10-01	사카타 인쿠스 가부시키가이샤	처리안료, 그 용도 및 안료처리용 화합물
GB0206033D0 (en)	2002-03-14	2002-04-24	Pfizer Ltd	Compounds useful in therapy
NZ538932A (en) *	2002-08-29	2007-04-27	Boehringer Ingelheim Pharma	3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative disease
US7598412B2 (en)	2003-10-08	2009-10-06	Vertex Pharmaceuticals Incorporated	Modulators of ATP-binding cassette transporters
JPWO2005040135A1 (ja)	2003-10-24	2007-03-08	小野薬品工業株式会社	抗ストレス薬およびその医薬用途
FR2870846B1 (fr) *	2004-05-25	2006-08-04	Sanofi Synthelabo	Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
EP1630158A1 (en)	2004-08-18	2006-03-01	Laboratorios Del Dr. Esteve, S.A.	5-HT7 receptor antagonists
ES2257168B1 (es)	2004-08-18	2007-06-01	Laboratorios Del Dr Esteve, S.A.	Ligandos del receptor 5-ht7.
US20080261999A1 (en)	2005-03-04	2008-10-23	Fionna Mitchell Martin	Azabicycloalkane Derivatives Useful as Nicotinic Acetylcholine Receptor Agonists
EP1790646A1 (fr)	2005-11-24	2007-05-30	Sanofi-Aventis	Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3.

2004
- 2004-05-25 FR FR0405607A patent/FR2870846B1/fr not_active Expired - Lifetime
2005
- 2005-05-23 JO JO200571A patent/JO2877B1/en active
- 2005-05-23 HN HN2005000239A patent/HN2005000239A/es unknown
- 2005-05-23 PE PE2005000566A patent/PE20060273A1/es not_active Application Discontinuation
- 2005-05-23 AR ARP050102107A patent/AR050250A1/es not_active Application Discontinuation
- 2005-05-24 PT PT57729386T patent/PT1753725E/pt unknown
- 2005-05-24 TW TW094116907A patent/TWI360540B/zh not_active IP Right Cessation
- 2005-05-24 KR KR1020067024780A patent/KR101176675B1/ko not_active Expired - Fee Related
- 2005-05-24 EA EA200602176A patent/EA010234B1/ru not_active IP Right Cessation
- 2005-05-24 GT GT200500126A patent/GT200500126A/es unknown
- 2005-05-24 BR BRPI0511581-7A patent/BRPI0511581A/pt not_active Application Discontinuation
- 2005-05-24 SI SI200531708T patent/SI1753725T1/sl unknown
- 2005-05-24 UY UY28917A patent/UY28917A1/es not_active Application Discontinuation
- 2005-05-24 PL PL05772938T patent/PL1753725T3/pl unknown
- 2005-05-24 EP EP05772938A patent/EP1753725B1/fr not_active Expired - Lifetime
- 2005-05-24 HR HRP20130431TT patent/HRP20130431T1/hr unknown
- 2005-05-24 MY MYPI20052337A patent/MY148980A/en unknown
- 2005-05-24 SV SV2005002126A patent/SV2006002126A/es active IP Right Grant
- 2005-05-24 CN CN200580016856.7A patent/CN1956962B/zh not_active Expired - Lifetime
- 2005-05-24 CA CA2565293A patent/CA2565293C/fr not_active Expired - Fee Related
- 2005-05-24 ES ES05772938T patent/ES2407140T3/es not_active Expired - Lifetime
- 2005-05-24 AU AU2005250197A patent/AU2005250197B2/en not_active Ceased
- 2005-05-24 ZA ZA200609820A patent/ZA200609820B/xx unknown
- 2005-05-24 DK DK05772938.6T patent/DK1753725T3/da active
- 2005-05-24 JP JP2007514007A patent/JP4861979B2/ja not_active Expired - Lifetime
- 2005-05-24 NZ NZ551509A patent/NZ551509A/en not_active IP Right Cessation
- 2005-05-24 MX MXPA06013629A patent/MXPA06013629A/es active IP Right Grant
- 2005-05-24 WO PCT/FR2005/001279 patent/WO2005118547A1/fr not_active Ceased
- 2005-05-24 UA UAA200613640A patent/UA84771C2/uk unknown
- 2005-05-25 PA PA20058634501A patent/PA8634501A1/es unknown
- 2005-05-25 DO DO2005000103A patent/DOP2005000103A/es unknown
2006
- 2006-11-02 IL IL179021A patent/IL179021A/en not_active IP Right Cessation
- 2006-11-03 TN TNP2006000356A patent/TNSN06356A1/en unknown
- 2006-11-07 CR CR8735A patent/CR8735A/es unknown
- 2006-11-15 US US11/559,929 patent/US7833999B2/en active Active
- 2006-11-22 EC EC2006007020A patent/ECSP067020A/es unknown
- 2006-11-23 NI NI200600279A patent/NI200600279A/es unknown
- 2006-12-04 MA MA29510A patent/MA28720B1/fr unknown
- 2006-12-19 NO NO20065918A patent/NO338104B1/no not_active IP Right Cessation
2010
- 2010-10-08 US US12/901,063 patent/US8273733B2/en not_active Expired - Lifetime
2012
- 2012-08-24 US US13/593,832 patent/US8524700B2/en not_active Expired - Lifetime
2013
- 2013-05-24 CY CY20131100411T patent/CY1114240T1/el unknown

Also Published As

Publication number	Publication date
JO2877B1 (en)	2015-03-15
CA2565293A1 (fr)	2005-12-15
US8524700B2 (en)	2013-09-03
CN1956962B (zh)	2014-08-20
KR20070021223A (ko)	2007-02-22
US8273733B2 (en)	2012-09-25
MXPA06013629A (es)	2007-03-23
KR101176675B1 (ko)	2012-08-23
HN2005000239A (es)	2009-04-27
JP4861979B2 (ja)	2012-01-25
MY148980A (en)	2013-06-28
AR050250A1 (es)	2006-10-11
EP1753725B1 (fr)	2013-02-27
CY1114240T1 (el)	2016-08-31
UY28917A1 (es)	2005-12-30
CA2565293C (fr)	2012-10-30
FR2870846A1 (fr)	2005-12-02
US7833999B2 (en)	2010-11-16
AU2005250197B2 (en)	2010-09-23
SV2006002126A (es)	2006-01-13
DK1753725T3 (da)	2013-05-27
ZA200609820B (en)	2008-06-25
DOP2005000103A (es)	2006-02-15
AU2005250197A1 (en)	2005-12-15
BRPI0511581A (pt)	2008-01-02
SI1753725T1 (sl)	2013-06-28
TNSN06356A1 (en)	2008-02-22
CR8735A (es)	2007-08-28
ECSP067020A (es)	2006-12-29
TWI360540B (en)	2012-03-21
US20120323003A1 (en)	2012-12-20
ES2407140T3 (es)	2013-06-11
GT200500126A (es)	2006-02-17
HRP20130431T1 (en)	2013-06-30
PA8634501A1 (es)	2006-05-16
JP2008500313A (ja)	2008-01-10
HK1106229A1 (en)	2008-03-07
TW200609220A (en)	2006-03-16
PE20060273A1 (es)	2006-04-22
WO2005118547A1 (fr)	2005-12-15
NI200600279A (es)	2008-01-22
NZ551509A (en)	2009-12-24
EA200602176A1 (ru)	2007-04-27
US20070105834A1 (en)	2007-05-10
MA28720B1 (fr)	2007-07-02
US20110028475A1 (en)	2011-02-03
NO20065918L (no)	2006-12-19
FR2870846B1 (fr)	2006-08-04
EA010234B1 (ru)	2008-06-30
NO338104B1 (no)	2016-08-01
CN1956962A (zh)	2007-05-02
EP1753725A1 (fr)	2007-02-21
PT1753725E (pt)	2013-05-21
UA84771C2 (uk)	2008-11-25
IL179021A0 (en)	2007-03-08
IL179021A (en)	2012-04-30

Publication	Publication Date	Title
IL180682A0 (en)	2007-06-03	N-hydroxamide derivatives, their preparation and use
IL192053A (en)	2014-01-30	2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation
IL212396A (en)	2015-09-24	6-oxo-1,6-dihydropyridazines and their use in drug preparation
IL181069A0 (en)	2007-07-04	Sulphonamide derivatives , their preparation and their therapeutic application
CR8037A (es)	2008-07-29	Derivados de 2- acilamino- 4- feniletiazol, su preparacion y su aplicacion en terapeutica
IL185163A0 (en)	2007-12-03	(1,5 - diphenyl - 1h - pyrazol - 3 - yl) oxadiazole derivatives, preparation method thereof and use of same in therapeutics
IL178402A0 (en)	2007-02-11	1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
IL180284A0 (en)	2007-07-04	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL182624A0 (en)	2007-07-24	2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof
IL177650A0 (en)	2006-12-31	Isoquinoline derivatives and methods of use thereof
IL180770A0 (en)	2007-06-03	Oxopiperidine derivatives, preparation and therapeutic use thereof
IL164463A (en)	2011-09-27	Use of osteoprotegerin in the preparation of medicaments
TWI350286B (en)	2011-10-11	Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy
AP2006003820A0 (en)	2006-12-31	Piperazin derivatives and their use in controllingpests
IL176769A0 (en)	2006-10-31	Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
IL180797A0 (en)	2007-06-03	Amino-tropane derivatives, preparation thereof and therapeutic use thereof
ZA200609820B (en)	2008-06-25	Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
IL188032A0 (en)	2008-03-20	Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics
IL182385A0 (en)	2007-07-24	Pyridine derivatives and the preparation and the therapeutic use thereof
ZA200903865B (en)	2010-08-25	Pyrrole derivatives, preparation and use of the same in therapy
IL191067A0 (en)	2008-12-29	Micronised azodicarbonamide, the preparation and use thereof
IL178598A0 (en)	2007-05-15	Skin-protecting alkalinity-controlling composition and the use thereof
ZA200800966B (en)	2009-04-29	Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
EP1813671A4 (en)	2008-06-11	SOLUBLE PROTEIN AND USE THEREOF
ZA200704806B (en)	2008-09-25	Novel betulin derivatives, preparation thereof and use thereof